Marshall Wace »

Humacyte shares owned by Marshall Wace

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $446k 157k 2.84
2023-09-30 $516k 176k 2.93
2022-09-30 $628k 193k 3.26
2022-06-30 $189k 59k 3.21

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Humacyte

Vanguard Group
Millennium Management
Prescott General Partners
Charles Schwab Investment Management
GSA Capital Partners
Two Sigma Investments
Private Advisor
Capstone Investment Advisors
Citadel Advisors
Lion Point Capital
United Asset Strategies
Marshall Wace
Bank of New York Mellon
Clough Capital Partners
Goldman Sachs Group

View all funds holding Humacyte